Events

Horizon Europe Cluster 6 & Missions / EU Matchmaking
MAR
Tue
25
00:00 - 00:00

This was 3 months ago

Location

Metz, France

Programmes
Agro-Food, Environment Missions

Horizon Europe Cluster 6 & Missions - Conference & Bilateral/B2B meetings

To pave the way for future Horizon Europe Cluster 6 & EU Missions calls 2025, Enterprise Europe Network (EEN) of Grand Est Développement (Grand E-Nov+) in close partnership with cross-border National Contact Points (NCPs) Networks and EEN from Wallonia and Luxembourg, we prepared this unique Matchmaking event:

  • 1 Plenary session: keep up to date with the latest news
  • 4 Thematic parallel workshops with pitching sessions: present your project idea, and expertise and be visible
  • 480 B2B meetings: build connections, initiate contacts with potential partners

For more information and to register for this event, please access its dedicated page via this link. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.